|
|
Volumn 47, Issue 1, 2002, Pages 17-21
|
|
Experience with etanercept in an academic medical center: Are infection rates increased?
|
|
Author keywords
Etanercept; Infection; Infection rates; Tumor necrosis factor alpha
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
HYDROXYCHLOROQUINE;
LEFLUNOMIDE;
METHOTREXATE;
SALAZOSULFAPYRIDINE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ANKYLOSING SPONDYLITIS;
ARTICLE;
BACTEREMIA;
BACTERIAL ARTHRITIS;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DOSE CALCULATION;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG TOLERANCE;
DRUG USE;
DRUG WITHDRAWAL;
FATALITY;
FEMALE;
GRAFT INFECTION;
HUMAN;
INFECTION;
INFECTION RATE;
JUVENILE RHEUMATOID ARTHRITIS;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
MYCOBACTERIUM INTRACELLULARE AVIUM;
POLYMYOSITIS;
PSOAS ABSCESS;
PSORIATIC ARTHRITIS;
RETROSPECTIVE STUDY;
RHEUMATOID ARTHRITIS;
TOTAL HIP PROSTHESIS;
UNIVERSITY HOSPITAL;
|
|
EID: 0036167283
PISSN: 21514658
EISSN: None
Source Type: Journal
DOI: 10.1002/art1.10243 Document Type: Article |
|
Times cited : (109)
|
|
References (12)
|
